The U.S. health care system relies heavily on a global supply chain for pharmaceuticals and medical devices. A significant portion of active pharmaceutical ingredients (APIs), especially for generic sterile injectables like chemotherapy drugs and antibiotics, are sourced from India and China. Similarly, complex medical devices often incorporate components from numerous countries. This global interdependence makes the health care sector particularly vulnerable to tariff-related disruptions.
Knowledge Center
Filter your results:
Type
Topic
9 Results Found
AHRMM Issues & Legislative (I&L) Committee identifies, reviews and follows the regulatory, environmental, quality of service and standards matters that impact the health care supply chain field. Each I&L Committee member closely monitors an important topic and compiles an update with useful information to help AHRMM members stay ahead of policy issues that affect their work and health care organization.
An update on current FDA and Congressional activity on independent service for reusable medical devices and the potential impact on your costs and level of service. Learn what you can do to get ready for potential changes that could affect your organization.
A sample of a bed management RFP covering all the basics. Download the document and tailor it to your needs.
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program to pay hospitals for their actual performance on quality measures, rather than just the reporting of those measures, beginning in fiscal year (FY) 2013. The VBP program will apply to all acute-care prospective payment system (PPS) hospitals. Read a summary of key provisions of the proposed rule.
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Education Reconciliation Act of 2010 in conjunction with the Patient Protection and Affordable Care Act.
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision making.
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.